Significantly, in another work, Koshikawa et al. showed that an engineered cleavage-resistant form of EphA2 reconstituted canonical signaling, thereby inhibiting tumor growth and metastasis formation in human tumor xenograft models [63]. This evidence concerns the gene EPHA2 and neoplasm.